Stifel Financial
OCRX

Stifel Financial’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Stifel Financial’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20,474
Closed -$23K – 2771
2017
Q3 		$23K Hold
20,474
– – ﹤0.01% 2546
2017
Q2 		$23K Sell
20,474
-1,800
-8% -$2.09K ﹤0.01% 2529
2017
Q1 		$30K Sell
22,274
-11,987
-35% -$15.3K ﹤0.01% 2487
2016
Q4 		$71K Buy
34,261
+1,713
+5% +$4K ﹤0.01% 2386
2016
Q3 		$88K Hold
32,548
– – ﹤0.01% 2297
2016
Q2 		$62K Sell
32,548
-167
-0.5% -$439 ﹤0.01% 2421
2016
Q1 		$96K Sell
32,715
-325
-1% -$927 ﹤0.01% 2115
2015
Q4 		$103K Sell
33,040
-2,000
-6% -$6.83K ﹤0.01% 2230
2015
Q3 		$111K Buy
35,040
+767
+2% +$2.95K ﹤0.01% 2125
2015
Q2 		$130K Buy
34,273
+434
+1% +$1.66K ﹤0.01% 2236
2015
Q1 		$159K Buy
33,839
+19,175
+131% +$111K ﹤0.01% 2148
2014
Q4 		$93K Buy
+14,664
New +$85.8K ﹤0.01% 2194

Stifel Financial's OCRX Position: Q4 2017 in Review

Stifel Financial sold out of Ocera Therapeutics, Inc. (OCRX) in Q4 2017, closing a stake of 20,474 shares — an estimated $23K sold.

Stifel Financial first reported a position in OCRX in Q4 2014 and held it in 12 quarters. The position peaked at $159K in Q1 2015. 0 funds tracked by Wall St. Rank hold OCRX as of Q4 2017.

  • Stifel Financial reported no remaining Ocera Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
  • Stifel Financial sold 20,474 Ocera Therapeutics, Inc. shares in Q4 2017, an estimated $23K.
  • Stifel Financial first reported a position in Ocera Therapeutics, Inc. in Q4 2014 and held it in 12 quarters.
  • Stifel Financial's Ocera Therapeutics, Inc. position peaked at $159K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q4 2017.

Based on Stifel Financial's 13F filing for Q4 2017, filed 14 Feb 2018.